Patents
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
12/2002
12/18/2002EP0784485B1 VACCINE COMPOSITIONS containing partially deacetylated chitin
12/18/2002EP0736002B9 Compound capable of introducing at least one molecule into a cell
12/18/2002EP0715523B1 Purine nucleoside phosphorylase gene therapy for human malignancy
12/18/2002EP0646019B9 Biotin-DOTA conjugates and their use in pretargeting methods
12/18/2002CN1386132A Antimicrobial composition
12/18/2002CN1386064A Granules based on starch and lactose
12/18/2002CN1386063A Cosmetic or pharmaceutical solid composition comprising bis-acyl-amides
12/18/2002CN1385457A 凝胶组合物 Gel compositions
12/18/2002CN1385214A Dissolvent specially for omeprazole sodium injection
12/18/2002CN1385149A Time-selection medicine releasing system
12/18/2002CN1096268C Tylosin containing sustained release veterinary compositions
12/18/2002CN1096263C Lipid complexes and liposomes of highly insoluble platnium complexes
12/17/2002WO2001097852A1 Aseptics
12/17/2002US6496727 Medicament-loaded transdermal reservoir and method for its formation
12/17/2002US6495718 Use of flavinoids in sorbate-preserved compositions, as color-stabilized cosmetic and pharmaceutical compositions
12/17/2002US6495680 A helical composition comprising a plurality of aromatic substituents linked by at least one amide group, the composition having a curved backbone due at least in part to intramolecular hydrogen bonds that rigidify the amide linkage
12/17/2002US6495669 Amphiphilic, polyhedron-shaped p-sulfonatocalix(4)arene building blocks, which have been shown previously to assemble into bilayers in an antiparallel fashion, assemble in a parallel alignment into spherical and helical tubular
12/17/2002US6495663 Method and composition for enhancing transport across biological membranes
12/17/2002US6495659 Water solubility
12/17/2002US6495608 Methods of performing surgery with galactomannan polymers and borate
12/17/2002US6495579 Administering to a multiple sclerosis patient a therapeutically effective amount of a paclitaxel formulation contining a homo or copopolymer
12/17/2002US6495535 Prefilled syringes or ampules for self administration containing dissolved carbon dioxide or nitrogen to retard oxidative degradation
12/17/2002US6495534 Stabilized aqueous suspensions for parenteral use
12/17/2002US6495518 Method for importing biologically active molecules into cells
12/17/2002US6495498 For cleansing hair, to impart superior wet stage and dry stage conditioning properties to the hair; for delivering benefit agents onto andlor into the surface of the skin, nails, and/or hair
12/17/2002US6495376 Phosphoserine and phosphothreonine binding modules. the ww-domain containing polypeptides of the invention can be used, for example, to regulate cell growth; to treat neurodegenerative diseases; to screen for substances that
12/17/2002US6495167 Preparation of powder agglomerates
12/17/2002US6495165 Eplerenone compositions having improved bioavailability
12/17/2002US6495164 Preparation of injectable suspensions having improved injectability
12/17/2002US6495163 Moisture barrier film coating composition, method and coated form
12/17/2002US6495160 Biphasic multicomponent pharmaceutical dosage forms containing substances able to modify the partitioning of drugs
12/17/2002US6495157 Starage stable suppositories comprising antibiotics in form of drug particles dispersed in fats used for treatment of urogenital disorders
12/17/2002US6495155 Injectable opioid partial agonist or opioid antagonist microparticle compositions and their use in reducing consumption of abused substances
12/17/2002US6495154 On demand administration of clomipramine and salts thereof to treat premature ejaculation
12/17/2002US6495148 High molecular weight polyuronic acids used as moisturizers and for prevention of skin disorders, ulcers, wrinkles, dryness or aging
12/17/2002CA2225808C Silver-based pharmaceutical compositions
12/17/2002CA2216569C Use of oxazolidinone derivatives as anti-penetrating agents in a cosmetic and/or dermatological composition
12/17/2002CA2144398C Composition containing a non photocatalytic metal oxide and tocopherol; use thereof in cosmetic and/or dermatological applications and processes implementing said composition
12/17/2002CA2132636C Rapamycin formulation for iv injection
12/17/2002CA2069153C Pharmaceutical composition
12/17/2002CA2068957C Pharmaceutical composition
12/17/2002CA2037408C A nonaqueous pharmaceutical macrolide solution
12/12/2002WO2002099379A2 Breast homing peptides and methods of identifying same using aminopeptidase p
12/12/2002WO2002099036A2 Inhibition of neurodegeneration
12/12/2002WO2002099026A1 Methods and formulations for enhancing the dissolution of a solid material in liquid
12/12/2002WO2002098952A1 Lipid-polymer-conjugates compositions
12/12/2002WO2002098951A2 Lipid-polymer-conjugates
12/12/2002WO2002098897A2 Modified antibodies to prostate-specific membrane antigen and uses thereof
12/12/2002WO2002098883A1 Methods for preparation of cytotoxic conjugates of maytansinoids and cell binding agents
12/12/2002WO2002098874A2 Inhalation capsules
12/12/2002WO2002098625A1 Method for injection moulding moulded bodies consisting of (meth)acrylate copolymers
12/12/2002WO2002098501A2 Method and apparatus for treating tumors using low strength electric fields
12/12/2002WO2002098482A2 System for osmotic delivery of pharmaceutically active agents
12/12/2002WO2002098465A2 Cell penetrating therapeutic agents
12/12/2002WO2002098464A2 Liquid polymer composition for prevention and treatment of the oral cavity diseases
12/12/2002WO2002098459A2 USE OF IgM ANTIBODIES AGAINST dsDNA IN SYSTEMIC LUPUS ERYTHEMATOSUS WITH NEPHRITIS
12/12/2002WO2002098453A2 Orally administering parathyroid hormone and calcitonin
12/12/2002WO2002098452A1 Mixtures of growth hormone drug-oligomer conjugates compromising polyalkylene glycol, uses thereof, and methods of making same
12/12/2002WO2002098451A1 Mixtures of calcitonin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
12/12/2002WO2002098447A1 Cytotoxic or radioactive conjugates able to bind to oxytocin receptors
12/12/2002WO2002098446A1 Mixtures of drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
12/12/2002WO2002098445A1 Protein preparation
12/12/2002WO2002098427A2 Sustained-release analgesic compounds
12/12/2002WO2002098423A1 S-omeprazole (esomeprazole) inclusion complex with cyclodextrins
12/12/2002WO2002098413A2 Pharmaceutical compositions comprising orlistat and fatty acids and/or salts thereof
12/12/2002WO2002098404A1 Topical compositions for veterinary uses
12/12/2002WO2002098401A1 Medicinal composition containing mucin
12/12/2002WO2002098392A1 Nsaid formulation comprising a granular composition and an extra-granular composition
12/12/2002WO2002098380A1 Preparation for the removal of abnormal keratin material
12/12/2002WO2002098365A2 Conditioned cell culture media and uses thereof
12/12/2002WO2002098364A2 Magnetic-nanoparticle conjugates and methods of use
12/12/2002WO2002098348A2 Glp-1 formulations with protracted time action
12/12/2002WO2002098339A2 Zinc containing compositions for anti-viral use
12/12/2002WO2002098232A1 Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
12/12/2002WO2002098226A1 Method for reducing muscle fatigue through administration of adenosine triphosphate
12/12/2002WO2002098222A1 Solutions of alkoxylated alkanol amide surfactants and antimicrobial compounds
12/12/2002WO2002089850A8 Long acting antimicrobic preparation
12/12/2002WO2002083891A3 Nucleic acids for inhibiting hairless protein expression and methods of use thereof
12/12/2002WO2002079232A3 Reducing the immunogenicity of fusion proteins
12/12/2002WO2002077000A3 Macrocyclic oligosaccharide derivatives which form manoscale assemblies
12/12/2002WO2002076508B1 Methods for delivering nucleic acid molecules into cells and assessment thereof
12/12/2002WO2002076432A3 Pharmaceutical composition comprising a poorly water-soluble active ingredient, a surfactant and a water-soluble polymer
12/12/2002WO2002074327A3 Compositions and methods for treating gonadotrophin related illnesses
12/12/2002WO2002064543A3 Novel succinate salt of o-desmethyl-venlafaxine
12/12/2002WO2002064093A3 Stabilized pharmaceutical and thyroid hormone compositions and method of preparation
12/12/2002WO2002064089A3 Methods of preventing ventilator associated pneumonia by oral administration of antimicrobial ib-367 peptides
12/12/2002WO2002062972A3 Hybridoma cell line g250 and its use for producing monoclonal antibodies
12/12/2002WO2002062843A3 Modified erythropoietin (epo) with reduced immunogenicity
12/12/2002WO2002059065A3 Oligo or polyalkylene glycol-coupled thrombin inhibitors
12/12/2002WO2002058586A3 Systemic formulations containing beta-carotene and derivatives thereof
12/12/2002WO2002056852A9 Cosmetics
12/12/2002WO2002047724A3 Coupling agent for introducing sound waves into the human body while reducing the amount of pain incurred
12/12/2002WO2002046232A3 Multimeric single-chain antibody with multiple antigen binding
12/12/2002WO2002045686A3 Pharmaceutical paste comprising an acid-labile active ingredient
12/12/2002WO2002013843A3 Chemotherapeutic agents conjugated to p97 and their methods of use in treating neurological tumours
12/12/2002WO2002009729A3 Treatment of hyperproliferative skin disorders and diseases
12/12/2002WO2002002077A3 Liposomal antineoplastic drugs and uses thereof
12/12/2002WO2002000246A8 Preparation containing an oxygen carrier for regeneration of the skin in the case of oxygen deficiency
12/12/2002US20020188281 Stabilized bioactive preparations and method of use
12/12/2002US20020188134 Pharmaceutical compositions